Beijing Succeeder Technology Inc. Stock

Equities

688338

CNE1000044C4

Medical Equipment, Supplies & Distribution

End-of-day quote Shanghai S.E. 06:00:00 2024-06-04 pm EDT 5-day change 1st Jan Change
22.32 CNY -1.85% Intraday chart for Beijing Succeeder Technology Inc. -4.70% -33.57%
Sales 2024 * 344M 47.46M Sales 2025 * 486M 67.06M Capitalization 2.37B 327M
Net income 2024 * 141M 19.45M Net income 2025 * 204M 28.15M EV / Sales 2024 * 6.89 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 4.87 x
P/E ratio 2024 *
16.9 x
P/E ratio 2025 *
11.6 x
Employees 296
Yield 2024 *
1.21%
Yield 2025 *
2.49%
Free-Float 39.66%
More Fundamentals * Assessed data
Dynamic Chart
Beijing Succeeder Technology Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Beijing Succeeder Technology Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Beijing Succeeder Technology Inc. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Beijing Succeeder Technology Inc. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Certain A Shares of Beijing Succeeder Technology Inc. are subject to a Lock-Up Agreement Ending on 7-AUG-2023. CI
Beijing Succeeder Technology to Market Device in European Union MT
Beijing Succeeder Technology Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Beijing Succeeder Technology Logs 7.2% Rise in 2022 Profit MT
Beijing Succeeder Technology Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Beijing Succeeder Technology Inc. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Beijing Succeeder Technology Inc. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Beijing Succeeder Technology Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Beijing Succeeder Technology Inc. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Beijing Succeeder Technology Inc. Reports Earnings Results for the Nine Months Ended September 30, 2021 CI
Beijing Succeeder Technology Inc. Reports Earnings Results for the Half Year Ended June 30, 2021 CI
More news
1 day-1.85%
1 week-4.70%
Current month-6.96%
1 month-10.65%
3 months-10.93%
6 months-33.35%
Current year-33.57%
More quotes
1 week
22.27
Extreme 22.27
24.11
1 month
22.27
Extreme 22.27
25.93
Current year
18.49
Extreme 18.49
34.23
1 year
18.49
Extreme 18.49
44.38
3 years
18.49
Extreme 18.49
47.30
5 years
18.49
Extreme 18.49
143.08
10 years
18.49
Extreme 18.49
143.08
More quotes
Managers TitleAgeSince
Founder 67 03-05-27
Chief Executive Officer 53 19-08-31
Director of Finance/CFO 47 16-05-29
Members of the board TitleAgeSince
Founder 67 03-05-27
Director/Board Member 51 04-06-30
Director/Board Member 53 04-03-31
More insiders
Date Price Change Volume
24-06-04 22.32 -1.85% 526 737
24-06-04 22.74 -1.00% 642,500
24-06-03 22.97 -4.25% 677,623
24-05-31 23.99 +2.09% 555,079
24-05-30 23.5 -0.89% 343,542

End-of-day quote Shanghai S.E., June 04, 2024

More quotes
Beijing Succeeder Technology Inc is a China-based company mainly engaged in the research and development, production and sales of testing instruments, reagents and consumables in the field of thrombosis and hemostasis in vitro diagnosis. The Company provides medical institutions with automated detection equipment for blood coagulation, blood rheology, hematocrit, platelet aggregation, and supporting reagents and consumables. Its products include testing instruments, reagents and consumables, such as automatic coagulation testers, coagulation quality control kits, Newtonian fluid quality controls, reaction cups and SAW blood rheology special cleaning. The Company operates its businesses within the domestic market and to overseas markets.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
22.32
Average target price
-
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 688338 Stock